Teclistamab Interactions
There are 409 drugs known to interact with teclistamab, along with 2 disease interactions. Of the total drug interactions, 57 are major, 337 are moderate, and 15 are minor.
- View all 409 medications that may interact with teclistamab
- View teclistamab disease interactions (2)
Most frequently checked interactions
View interaction reports for teclistamab and the medicines listed below.
- Aleve (naproxen)
- Ativan (lorazepam)
- Atrovent Nasal (ipratropium nasal)
- Augmentin (amoxicillin / clavulanate)
- Bactrim (sulfamethoxazole / trimethoprim)
- Breo Ellipta (fluticasone / vilanterol)
- Carafate (sucralfate)
- Claritin (loratadine)
- Colace (docusate)
- Compazine (prochlorperazine)
- Crestor (rosuvastatin)
- Darzalex Faspro (daratumumab / hyaluronidase)
- Dilaudid (hydromorphone)
- DuoNeb (albuterol / ipratropium)
- Effexor XR (venlafaxine)
- Eliquis (apixaban)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flexeril (cyclobenzaprine)
- Flonase (fluticasone nasal)
- Lasix (furosemide)
- Lexapro (escitalopram)
- Lyrica (pregabalin)
- Maxalt (rizatriptan)
- MiraLAX (polyethylene glycol 3350)
- Mirapex (pramipexole)
- Morphine Sulfate ER (morphine)
- MVI Adult (multivitamin)
- Norvasc (amlodipine)
- Octagam (immune globulin intravenous)
- Pomalyst (pomalidomide)
Teclistamab disease interactions
There are 2 disease interactions with teclistamab which include:
More about teclistamab
- teclistamab consumer information
- Compare alternatives
- Reviews (6)
- Side effects
- Dosage information
- During pregnancy
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.